Literature DB >> 16984302

Are flexible designs sound?

Carl-Fredrik Burman1, Christian Sonesson.   

Abstract

Flexible designs allow large modifications of a design during an experiment. In particular, the sample size can be modified in response to interim data or external information. A standard flexible methodology combines such design modifications with a weighted test, which guarantees the type I error level. However, this inference violates basic inference principles. In an example with independent N(mu, 1) observations, the test rejects the null hypothesis of mu < or = 0 while the average of the observations is negative. We conclude that flexible design in its most general form with the corresponding weighted test is not valid. Several possible modifications of the flexible design methodology are discussed with a focus on alternative hypothesis tests.

Mesh:

Year:  2006        PMID: 16984302     DOI: 10.1111/j.1541-0420.2006.00626.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  11 in total

Review 1.  Adaptive trial designs.

Authors:  Tze Leung Lai; Philip William Lavori; Mei-Chiung Shih
Journal:  Annu Rev Pharmacol Toxicol       Date:  2011-08-11       Impact factor: 13.820

2.  GLUMIP 2.0: SAS/IML Software for Planning Internal Pilots.

Authors:  John A Kairalla; Christopher S Coffey; Keith E Muller
Journal:  J Stat Softw       Date:  2008-11-13       Impact factor: 6.440

3.  Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.

Authors:  Peter Bauer; Frank Bretz; Vladimir Dragalin; Franz König; Gernot Wassmer
Journal:  Stat Med       Date:  2015-03-16       Impact factor: 2.373

4.  Adaptive Budgets in Clinical Trials.

Authors:  Martin Posch; Peter Bauer
Journal:  Stat Biopharm Res       Date:  2013-04-04       Impact factor: 1.452

5.  Meeting the demand for more sophisticated study designs. A proposal for a new type of clinical trial: the hybrid design.

Authors:  Guoxing G Soon; Lei Nie; Thomas Hammerstrom; Wen Zeng; Haitao Chu
Journal:  BMJ Open       Date:  2011-01-01       Impact factor: 2.692

6.  Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications.

Authors:  Alexandra C Graf; Peter Bauer; Ekkehard Glimm; Franz Koenig
Journal:  Biom J       Date:  2014-04-22       Impact factor: 2.207

7.  Flexible selection of a single treatment incorporating short-term endpoint information in a phase II/III clinical trial.

Authors:  Nigel Stallard; Cornelia Ursula Kunz; Susan Todd; Nicholas Parsons; Tim Friede
Journal:  Stat Med       Date:  2015-06-26       Impact factor: 2.373

8.  Familywise error control in multi-armed response-adaptive trials.

Authors:  D S Robertson; J M S Wason
Journal:  Biometrics       Date:  2019-04-03       Impact factor: 2.571

9.  Sample size re-assessment leading to a raised sample size does not inflate type I error rate under mild conditions.

Authors:  Per Broberg
Journal:  BMC Med Res Methodol       Date:  2013-07-19       Impact factor: 4.615

10.  Estimation after blinded sample size reassessment.

Authors:  Martin Posch; Florian Klinglmueller; Franz König; Frank Miller
Journal:  Stat Methods Med Res       Date:  2016-10-02       Impact factor: 3.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.